Curis: 4 Reasons To Consider This $4 Stock [View article]
Mvdolphin, You participated in their clinical trial? How did it go?
Yes, I am in the thought process of writing a very embarassing article about Curis management and their Board. The are one of the most incompetent teams in any biotech I have ever experienced. Just look at the results of what they have accomplished after 10+ years (do not include vismodegib...because that was all Roche-Genentech-----if Dan Paserri had been in charge of that drug, vismodegib would still be in a 10 person Phase 1 exploratory study; heck, he might have even gone with an IV formula instead of oral). BTW, if you have ever called the company looking for their CEO, good luck. I often wonder if he even actually works in the office for more than 20 hours a week. What exactly he does all day is truly beyond my comprehension.
Not to mention, they sell stock after they promote other shareholders to buy it.
Curis: A Stock Fueled By Sonic Hedgehog [View article]
That was on the assumption (1) Roche would be actively marketing the drug (they're not, they have no real plan), (2) pancreatic data would pan out (it hasn't, it doesn't look special at all), (3) management wouldn't have shown their incompetence, carelessness, and lack of respect for public shareholders.
I was wrong. I will exit position on any strength, but not selling here.
If the company hired a new CEO and fired their current CEO and got a Financial Officer who understands how a biotech company should be run, I would consider adding more shares.
A Quick Response To Ariad's Conference Call [View article]
8x8 Inc: Compelling Acquisition Play Could Fetch Price Of $1 Billion [View article]
Dont forget to have your mommy tuck you in tonight right after you get done breast feeding.
8x8 Inc: Compelling Acquisition Play Could Fetch Price Of $1 Billion [View article]
Wait until your ARIA gaps down 50% shortly. Thats going to be a real hoot.
8x8 Inc: Compelling Acquisition Play Could Fetch Price Of $1 Billion [View article]
When was the last article on CRIS? Last year in April?? LOL
Have mommy tuck you in.
8x8 Inc: Compelling Acquisition Play Could Fetch Price Of $1 Billion [View article]
8x8 Inc: Compelling Acquisition Play Could Fetch Price Of $1 Billion [View article]
You were arguing EGHT would go out of business at 3.00 last year.
Good work, lol.
8x8 Inc: Compelling Acquisition Play Could Fetch Price Of $1 Billion [View article]
8x8 Inc: Compelling Acquisition Play Could Fetch Price Of $1 Billion [View article]
You really dont sound like you even know your own industry if you are comparing VG to EGHT.
VG is residential, 8x8 hasnt been residential for years and is strictly enterprise and SMB delivery.
BTW, SHOR paid 6x revs last year for M5
8x8 Inc: Compelling Acquisition Play Could Fetch Price Of $1 Billion [View article]
Carsons, you are a complete idiot. Do you understand what a hedge fund manager does?
8x8 Inc: Compelling Acquisition Play Could Fetch Price Of $1 Billion [View article]
All computer generated algorithms that simply crunch numbers = worthless.
8x8 Inc: Compelling Acquisition Play Could Fetch Price Of $1 Billion [View article]
Upcoming AML Treatments - Which Company Will Fly? [View article]
Curis: 4 Reasons To Consider This $4 Stock [View article]
You participated in their clinical trial? How did it go?
Yes, I am in the thought process of writing a very embarassing article about Curis management and their Board. The are one of the most incompetent teams in any biotech I have ever experienced. Just look at the results of what they have accomplished after 10+ years (do not include vismodegib...because that was all Roche-Genentech-----if Dan Paserri had been in charge of that drug, vismodegib would still be in a 10 person Phase 1 exploratory study; heck, he might have even gone with an IV formula instead of oral). BTW, if you have ever called the company looking for their CEO, good luck. I often wonder if he even actually works in the office for more than 20 hours a week. What exactly he does all day is truly beyond my comprehension.
Not to mention, they sell stock after they promote other shareholders to buy it.
Article coming.
Curis: A Stock Fueled By Sonic Hedgehog [View article]
I was wrong. I will exit position on any strength, but not selling here.
If the company hired a new CEO and fired their current CEO and got a Financial Officer who understands how a biotech company should be run, I would consider adding more shares.
Curis: A Stock Fueled By Sonic Hedgehog [View article]
Fleecing shareholders now for years.
same old Board, same old management.